Powered by HealthTechMovers.com
We added 2 stocks to our Healthcare & Biotech Stock Watchlist today because they are receiving Bullish Sentiment from investors and financial bloggers.
In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention. This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.
Harmony Biosciences Holdings, HRMY
Summary: Harmony Biosciences Holdings Inc.is a pharmaceutical company. It engages in developing and commercializing therapies for rare neurological disorders. Harmony Biosciences Holdings Inc.is based in Plymouth Meeting, Pennsylvania.
- Last Price: 41.1
- Price Change: 0.24, 0.59%
- Yearly Gain: 14.58%
- Market Cap: 2.40B
- P/E Ratio: 21
Here are 3rd party ratings for HRMY:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Sell, Bottom 38% (157 out of 254)
What is the sentiment on the street regarding Harmony Biosciences Holdings ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Medium
- Insider Signal: Neutral
- Investor Sentiment: Very Positive
- Hedge Fund signal: Positive
If you are interested in HRMY or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on HRMY before you decide to make any investment.
Click here for chart >>
Prometheus Biosciences, RXDX
Summary: Prometheus Biosciences Inc. is a biotechnology company. It involved in the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease. Prometheus Biosciences Inc. is based in SAN DIEGO.
- Last Price: 33
- Price Change: 3.19, 10.70%
- Yearly Gain: 17.87%
- Market Cap: 1.28B
- P/E Ratio: -10.1
Here are 3rd party ratings for RXDX:
- TipRanks.com: Strong Buy
- TradingView.com: Strong Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: n/a
- Zacks.com: Sell, Bottom 38% (157 out of 254)
What is the sentiment on the street regarding Prometheus Biosciences ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Medium
- Insider Signal: Positive
- Investor Sentiment: Very Positive
- Hedge Fund signal: Positive
If you are interested in RXDX or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on RXDX before you decide to make any investment.
Click here for chart >>
Thanks for reading!